Home > Press > Pharmaceutical Industry Needs to Jump the Curve to Nanotech
In 2003, I wrote the book, "The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business." In it, I outlined the many ways in which nanotechnology will impact the pharmaceutical industry in the near future. Recently, researchers at Children's Hospital in Boston have uncovered a method of reviving a once-promising cancer drug, TNP-470—which was cancelled in the mid-1990's due to concerns over toxicity.
Pharmaceutical Industry Needs to Jump the Curve to Nanotech
Minneapolis, MN | Posted on July 11th, 2008
The problem of toxicity is not a new one to the pharmaceutical industry. In fact, it is a big reason why so many early stage drugs fail to make it to market.
This vexing problem may soon be partially alleviated due to advances in nanotechnology. One advantage of reformulating drugs at the nanoscale is that they are water soluble and, as such, don't require the solvents which so often cause nasty side-effects in patients.
Another application being employed from the nanotechnology bag of tricks is to use nanoscale platforms such as micelles and dendrimers to prevent drugs from crossing the blood-brain barrier. In this fashion, older drugs may be reformulated so as to prevent certain drugs from wreaking havoc on the human brain. (This was one of the problems with TNP-470).
The pharmaceutical industry has invested billions of dollars developing promising drugs. Unfortunately, most developmental drugs end being shelved when it is found they cause some unintended consequence. Nanotechnology holds the promise that a handful of older drugs may now be revisited. Some may even find their way to the commercial marketplace.
With a single drug's ability to add billions of dollars to a pharmaceutical company's bottom-line, it is time many of them begin turning their attention to nanotechnology. It's a small technology, but it could pay big dividends.
About Jack Uldrich
Jack Uldrich is a renowned global futurist, independent scholar, sought-after business speaker, and best-selling author. His books include the best-selling, The Next Big Thing is Really Small: How Nanotechnology Will Change the Future of Your Business, and the award-winning, Into the Unknown: Leadership Lessons from Lewis & Clark’s Daring Westward Expedition. His latest book is Jump the Curve: 50 Essential Strategies to Help Your Company Stay Ahead of Emerging Technologies.
For more information, please click here
Copyright © Jack Uldrich
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
News and information
SEMATECH to Showcase Innovation and Advances in Manufacturing at SEMICON Japan 2014: SEMATECH experts will share the latest techniques, emerging trends and best practices in advanced manufacturing strategies and methodologies November 26th, 2014
Australian startup creates world’s first 100% cotton hydrophobic T-Shirts November 26th, 2014
The mysterious 'action at a distance' between liquid containers November 26th, 2014
'Giant' charge density disturbances discovered in nanomaterials: Juelich researchers amplify Friedel oscillations in thin metallic films November 26th, 2014
Graphene chips are close to significant commercialization October 1st, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Produced Water Absorbents, Inc. July 9th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With HZO, Inc. June 12th, 2014
3D printing and microrobots making progress on building tissue with blood vessels which will enable large printed organs June 1st, 2014
Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014
Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014
ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014
An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014